...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Re: eGFR and Cognition?
8
Nov 22, 2019 11:47AM
10
Nov 22, 2019 12:28PM
9
Nov 22, 2019 01:10PM
2
Nov 22, 2019 01:49PM
7
Nov 22, 2019 04:05PM
1
Nov 22, 2019 04:22PM
4
Nov 22, 2019 04:38PM
16
Nov 22, 2019 04:47PM
2
Nov 22, 2019 05:10PM
5
Nov 22, 2019 05:16PM
7
Nov 22, 2019 05:21PM
2
Nov 22, 2019 05:34PM
1
Nov 22, 2019 05:58PM
3
Nov 22, 2019 06:19PM
5
Nov 22, 2019 08:14PM
1
Nov 22, 2019 10:29PM
6
Nov 22, 2019 10:48PM
6
Nov 22, 2019 11:19PM
5
Nov 22, 2019 11:43PM
1
Nov 23, 2019 07:08AM
8
Nov 23, 2019 07:20AM
4
Nov 23, 2019 07:23AM
1
Nov 23, 2019 08:05AM
3
Nov 23, 2019 09:06AM
9
Nov 23, 2019 09:24AM
4
Nov 23, 2019 09:58AM
3
Nov 23, 2019 12:31PM
4
Nov 23, 2019 03:28PM
1
Nov 23, 2019 04:31PM
3
Nov 23, 2019 04:49PM
5
Nov 23, 2019 05:09PM
6
Nov 23, 2019 06:16PM
4
Nov 23, 2019 06:55PM
5
Nov 23, 2019 06:59PM
2
Nov 23, 2019 07:11PM
9
Nov 23, 2019 08:15PM
6
Nov 23, 2019 09:19PM
4
Nov 25, 2019 01:39AM
3
Nov 25, 2019 02:14AM
2
Nov 25, 2019 02:16AM
5
Nov 25, 2019 02:40AM
2
Nov 25, 2019 02:48AM
1
Nov 25, 2019 08:03AM

This is the FDA page on the definition of a breakthrough therapy.

 https://www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/fact-sheet-breakthrough-therapies

There has to be preliminary evidence of “substantial” benefit. A little under 50 % of applications are granted.

Could be for STLG2, CHF, GFR, dementia.

3
Nov 25, 2019 10:20AM
5
Nov 25, 2019 02:39PM
Share
New Message
Please login to post a reply